中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [19]
金属研究所 [5]
采集方式
OAI收割 [24]
内容类型
期刊论文 [24]
发表日期
2020 [1]
2016 [4]
2015 [4]
2014 [4]
2013 [6]
2012 [4]
更多
学科主题
筛选
浏览/检索结果:
共24条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Synthesis of triazolotriazine derivatives as c-Met inhibitors
期刊论文
OAI收割
MOLECULAR DIVERSITY, 2020, 页码: 8
作者:
  |  
收藏
  |  
浏览/下载:49/0
  |  
提交时间:2020/12/24
Receptor tyrosine kinase
c-Met
Triazolotriazine
SAR
Cellular potency
Discovery of 6-(difluoro(6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b] [1,2,4]triazin-3-yl)methyl)quinoline as a highly potent and selective c-Met inhibitor
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 卷号: 116, 页码: 239-251
作者:
Zhan, Zhengsheng
;
Peng, Xia
;
Liu, Qiufeng
;
Chen, Fang
;
Ji, Yinchun
  |  
收藏
  |  
浏览/下载:59/0
  |  
提交时间:2019/01/08
Antitumor
c-Met
Kinase inhibitor
Triazolotriazines
Simm530, a novel and highly selective c-Met inhibitor, blocks c-Met-stimulated signaling and neoplastic activities
期刊论文
OAI收割
ONCOTARGET, 2016, 卷号: 7, 期号: 25, 页码: 38091-38104
作者:
Wang, Ying
;
Zhan, Zhengsheng
;
Jiang, Xifei
;
Peng, Xia
;
Shen, Yanyan
  |  
收藏
  |  
浏览/下载:68/0
  |  
提交时间:2019/01/08
c-Met
kinase inhibitor
Simm530
Discovery of a new series of imidazo1,2-apyridine compounds as selective c-Met inhibitors
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 5, 页码: 698-707
作者:
Liu Tongchao
;
Peng Xia
;
Ma Yuchi
;
Ji Yinchun
;
Chen Danqi
  |  
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2021/02/02
RECEPTOR TYROSINE KINASE
INVASIVE GROWTH
SCATTER FACTOR
CANCER
DOCKING
c-Met inhibitors
hepatocyte growth factor receptor
imidazo1,2-apyridine
anticancer agents
drug discovery
Discovery of a new series of imidazo1,2-apyridine compounds as selective c-Met inhibitors
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 5, 页码: 698-707
作者:
Liu Tongchao
;
Peng Xia
;
Ma Yuchi
;
Ji Yinchun
;
Chen Danqi
  |  
收藏
  |  
浏览/下载:48/0
  |  
提交时间:2021/02/02
RECEPTOR TYROSINE KINASE
INVASIVE GROWTH
SCATTER FACTOR
CANCER
DOCKING
c-Met inhibitors
hepatocyte growth factor receptor
imidazo1,2-apyridine
anticancer agents
drug discovery
Design, Synthesis, and Biological Evaluation of Novel Imidazo[1,2-a]pyridine Derivatives as Potent c-Met Inhibitors
期刊论文
OAI收割
ACS MEDICINAL CHEMISTRY LETTERS, 2015, 卷号: 6, 期号: 5, 页码: 507-512
作者:
Li, Chunpu
;
Ai, Jing
;
Zhang, Dengyou
;
Peng, Xia
;
Chen, Xi
  |  
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2019/01/08
Receptor tyrosine kinase
c-Met inhibitor
imidazo[1,2-a]pyridine
metabolic stability
Discovery and SAR study of c-Met kinase inhibitors bearing an 3-amino-benzo[d] isoxazole or 3-aminoindazole scaffold
期刊论文
OAI收割
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 卷号: 23, 期号: 3, 页码: 564-578
作者:
Jiang, Xiaolong
;
Liu, Hongyan
;
Song, Zilan
;
Peng, Xia
;
Ji, Yinchun
  |  
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2019/01/08
c-Met kinase
Inhibitor
3-Amino-benzo[d]isoxazole
3-Aminoindazole
Non-small cell lung cancer
Discovery of potent 1H-imidazo[4,5-b]pyridine-based c-Met kinase inhibitors via mechanism-directed structural optimization
期刊论文
OAI收割
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 卷号: 25, 期号: 3, 页码: 708-716
作者:
An, Xiao-De
;
Liu, Hongyan
;
Xu, Zhong-Liang
;
Jin, Yi
;
Peng, Xia
  |  
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2019/01/08
c-Met tyrosine kinase
Small molecule inhibitor
Imidazonaphthyridinone
Imidazopyridine
Binding mode
Pyridone-3-carboxamide
Cyclopropane-1,1-dicarboxamide
Design, Synthesis and Pharmacological Evaluation of Novel 4-Phenoxyquinoline Derivatives as Potential Antitumor Agents
期刊论文
OAI收割
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2015, 卷号: 31, 期号: 5, 页码: 746-755
作者:
Hu Hao
;
Jiang Mingyan
;
Xie Lijun
;
Hu Gang
;
Zhang Cuirong
  |  
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2021/02/02
MET KINASE INHIBITORS
GROWTH-FACTOR RECEPTOR
C-MET
6,7-DISUBSTITUTED-4-PHENOXYQUINOLINE DERIVATIVES
BIOLOGICAL EVALUATION
DISCOVERY
MOIETY
BEARING
IDENTIFICATION
4-Phenoxyquinoline derivative
Cytotoxic activity
3-Amino-2-cyano-acrylamide
SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo
期刊论文
OAI收割
CANCER LETTERS, 2014, 卷号: 351, 期号: 1, 页码: 143-150
作者:
Wang, Lu
;
Ai, Jing
;
Shen, Yanyan
;
Zhang, Haotian
;
Peng, Xia
  |  
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2019/01/08
c-Met
SOMCL-863
Receptor tyrosine kinase
Cancer
Angiogenesis